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ABSTRACT
European studies have shown that approximately 20%
of all pollen-allergic patients display IgE reactivity to
various plant profilins. Profilins are ubiquitous intra-
cellular proteins, with a role in cell signalling and
morphology. Recently, functionally relevant human
profilin tetramers were identified, but the characteriza-
tion and allergenic roles of plant profilin multimers
have not been reported. Because larger molecules are
generally more antigenic, the present objectives were
to: (i) determine if plant profilin forms multimers; (ii)
use the allergenic property of profilin in the design of
an immunoassay to detect type I allergies in the local
population; and (iii) assess the allergenic potential of
monomeric versus multimeric profilin. In agreement
with other known profilin forms, silver-stained sodium
dodecyl sulfate–polyacrylamide gel electrophoresis
and immunoblot analyses revealed that a significant
14.8 kDa protein was purified from Escherichia coli
transformed with the cDNA of a plant (Zea mays)
profilin isoform (ZmPRO1). Higher molecular weight
proteins (particularly 60 kDa and 30 kDa) were also
observed, which became predominant and larger 
(> 90 kDa) in the absence of reducing agents. Human
IgE reactivity to profilin was measured by enzyme-
linked immunosorbent assay (ELISA) that was
developed using patient serum samples classified as
either negative (no type I allergies), positive (type I
plant allergies) or miscellaneous (i.e. allergies other
than classical type I plant allergies). The IgE-ZmPRO1
complexes were seen in three of nine patients with type
I plant allergies, compared with one of eight negative
controls and three of 14 from the miscellaneous cate-
gory. Dot filtration immunoblots were subsequently
developed to absorb profilin diluted in the presence or
absence of reducing agent to yield mostly monomeric
or multimeric profilin, respectively. Immunoglobulin E
from positive patients displayed a greater intensity of
binding to ZmPRO1 under conditions that favored
profilin multimers. In summary, recombinant ZmPRO1
profilin forms multimers and is suitable for a devel-
oped ELISA. The data further suggest that profilin has
pan-allergenic potential in the North American popu-
lation and raise the possibility that profilin multimers
have greater immunogenicity than monomers.
Key words: allergy, diagnostic, multimer, oligomer-
ization, plant profilin, profilin.
INTRODUCTION
Profilins are cytoskeletal proteins that sequester G-actin
and bind to membrane-associated phosphatidylinositol-
4,5-bisphosphate,1–7 thereby affecting both cell morphol-
ogy and signal transduction. Recently, the existence of
human profilin multimers has been reported, in which
tetramers may be the high-affinity actin-binding form.8
Profilins have also been identified and purified from tree,
grass and weed pollens and have been produced recom-
binantly.9–14 European studies have revealed that profilin
isoforms isolated from various plant sources may act as
pan-allergens9,10,15,16 and that approximately 20% of all
pollen-allergic patients display IgE reactivity to recombi-
nant birch profilin. The recombinant birch profilin, as 
well as natural profilins from birch, timothy grass and
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mugwort, are able to elicit IgE-mediated histamine release
from basophils of pollen-allergic patients. Thus, profilin
may be a pan-allergen as well as being responsible 
for the sensitization and maintenance of a significant
number of type I allergic patients.
Structural analysis has revealed remarkable homology
between profilins from different plant species.9–11 Plant
profilins appear to share common IgE epitopes and IgE
from all sensitive patients cross-reacts with different pro-
filins. In addition, rabbit polyclonal antibodies raised
against recombinant birch profilin16 cross-react with virtu-
ally all plant profilins studied thus far. The available data
indicate that profilin from one plant source can cross-
sensitize an individual to several plant species and may
explain why some patients with type I hypersensitivities
display reactions to a wide range of distantly related
pollens and foods.
Available data regarding profilin as a pan-allergen
have thus far been drawn from European patients,
whereas sensitivity of the North American population to
plant profilin is unknown. Furthermore, the ability of plant
profilin to form multimers has not been directly studied.
However, the existence of multimers should be con-
sidered when investigating the allergenic properties of
profilin, because larger antigens would likely present
additional epitopes to elicit a greater IgE-mediated hista-
mine release. Therefore, recombinant plant profilin multi-
merization was studied and immunoassays were devel-
oped to assess IgE reactivity of individuals to plant
profilin. The correlation between type I hypersensitivities




The cDNA encoding an isoform of profilin derived from
the pollen of Zea mays (ZmPRO1; courtesy of Dr
Christopher Staiger, Purdue University, West Lafayette,
IN, USA)17 was provided in a transfection vector (pET-
23a; Novagen, Madison, WI, USA) with an isopropyl
beta-D-thiogalactopyranoside (IPTG)-inducible pro-
moter; polyclonal rabbit IgG that recognizes the protein
product encoded by ZmPRO1 cDNA was also provided.
Cyanogen bromide (CNBr)-activated sepharose 4B was
purchased from Pharmacia (Piscataway, NJ, USA) and
poly(L -proline) (PLP; 10 000–30 000 MW) was pur-
chased from Sigma Chemical Co. (St Louis, MO, USA).
Horseradish peroxidase (HRP)-conjugated monoclonal
antibodies (goat antirabbit IgG, goat antihuman IgE) and
silver staining kits were purchased from Pierce Chemical
Co. (Rockford, IL, USA).
Patient serum samples
Human serum samples from routine blood draws
were kindly provided by the University of Illinois College
of Medicine at Rockford, Office of Family Practice
(Rockford, IL, USA) with appropriate patient consent;
patient-declared allergies were annotated on each serum
container. Serum isolated from whole blood by standard
centrifugational methods was either stored at 4°C (and
used within 1 week) or aliquoted and stored at – 20°C.
The samples were categorized into one of three groups:
(i) no declared allergies; (ii) miscellaneous reactions
(i.e. non-plant allergens, such as dust, adhesive tape,
synthetic materials etc.); or (iii) classical type I allergies to
plant pollens.
Expression and purification of ZmPRO1
profilin
Pre-thawed competent BL21(DE3) Escherichia coli cells
(Novagen Inc., Madison, WI, USA) were transformed with
ZmPRO1/pET-23a by a modified protocol from the manu-
facturer and essentially as described for plant11,13,18 and
human profilins.19 The DNA content and quality from
lysates of various transformed E. coli clones were ana-
lyzed by standard spectrophotometric measurement 
(i.e. 260 nm, concentration; 260 nm/280 nm, relative
nucleotide purity vs protein) and agarose (0.7%) gel elec-
trophoresis. The E. coli clones expressing the highest
concentrations of ZmPRO1 cDNA were selected for pro-
filin production.
Transformed E. coli initially grown in 10 mL L-broth
(in g/L: 10 tryptone, 5 bacto yeast extract, 10 NaCl +
0.15 ampicillin) at 37°C for 10 h were brought to a final
1 L volume of L-broth and incubated for an additional 
2 h (37°C, gentle mixing at 100 r.p.m.) prior to the addi-
tion of either IPTG (0.4 mmol/L final concentration) or
vehicle for an additional 6 h incubation. The cultures
were centrifuged (1000 g for 30 min at 22°C) to yield
pellets that were resuspended in 5 volumes of ice-cold
lysis buffer (0.01% Triton X-100, 2 m mol/L leupeptin,
1 m mol/L aprotinin, 0.2 m mol/L pepstatin, 5 mmol/L
This-HCl, pH 7.2) and sonicated (continuous output
control setting 2 · 10 s, Sonifier cell disruptor, Branson
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Sonic Power Co., Danbury, CT, USA). The lysates were
centrifuged (12 000 g for 30 min at 4°C) and super-
natants poured ontoa poly(L-proline)-sepharose 4B (i.e.
PLP bead) affinity column, as described previously.8,20
Briefly, a step-wise elution gradient with urea was used 
to collect and purify profilin for overnight dialysis 
(at 4°C) against 2 mmol/L N-2-hydroxyethylpiperazine-
N¢ -2-ethanesulfonic acid (HEPES), pH 7.2/0.1 mmol/L
CaCl2 and concentration by centrifugation (centriplus-3,
Amicon Inc., Beverly, MA, USA) to a final concentration
of approximately 1 mg/mL, which was stored at – 20°C.
In some cases, ZmPRO1 profilin was isolated by a 
co-incubation of E. coli lysate:PLP bead slurry (1:4 vol;
4–16 h at 4°C, gentle shaking), followed by centrifuga-
tion to pellet and wash the profilin-PLP bead complexes
(3 times with 100 mmol/L NaCl, 100 mmol/L glycine,
0.01 mmol/L DTT, 10 mmol/L Tris base, pH 7.8). The
final pellet was suspended and boiled in sample buffer,
with or without b -mercaptoethanol (BME).
Proteins isolated by either PLP bead slurry (e.g. Fig. 1;
initial purification and validation that profilin was made in
E. coli) or column chromatography were analyzed by stan-
dard silver-stained sodium dodecyl sulfate–polyacrylamide
gel electropheresis (SDS-PAGE; 15% acrylamide) tech-
niques. Profilin was further characterized by western
immunoblotting, as previously described.8 The immuno-
blot was developed by incubation with rabbit anti-
ZmPRO1 primary antibody (1:1000) and goat antirabbit
secondary antibody conjugated with horseradish peroxi-
dase (1:500). Proteins were visualized with either a
fluorescent substrate or enhanced metal substrate (Super
Signal or metal diaminobenzidine tetrahydrochloride (DAB),
Pierce Chemical Co., Rockford, IL, USA).
Enzyme-linked immunosorbent assay for
human IgE-ZmPRO1 profilin detection
Purified ZmPRO1 product (50 ng/well) or a control
vehicle (tris-buffered saline (TBS), pH 7.4) was added 
to designated wells of a 96-well immunoassay plate
(Immulon-2, Dynatech Laboratories Inc., Chantilly, VA,
USA) that was stored overnight at 4°C. The general
sequence to develop the appropriate wells for the ELISA
was as follows: (i) block non-specific sites (4% non-fat
powdered milk, 0.1% bovine serum albumin (BSA),
0.02% NaN3 in TBS, 20% SuperBlock from Pierce
Chemical Co. for 2 h at 4°C); (ii) 1 · TBS wash and incu-
bate with either serum samples or a control vehicle (TBS
or heat-inactivated fetal calf serum; overnight at 4°C); (iii)
discard samples and add either TBS to sample wells or
primary rabbit IgG antiplant profilin (1:1000 dilution in
TBS, 0.01% Tween-20, 0.01% BSA for 1.5 h) into control
wells to ensure ZmPRO1 profilin coating; and (iv) 1 ·
TBS wash of all wells, add appropriate secondary anti-
bodies (either goat antihuman IgE-HRP in wells that
contained serum or goat antirabbit IgG-HRP in control
wells; 1:500 dilutions for 2 h at 4°C). The plate was
extensively washed then developed using 2,2¢ -azino-bis
(3-ethylbenzthiazoline-6-sulfonic acid) as a colorimetric
method substrate (although other established HRP sub-
strates were also successful in preliminary work) and
optical densities were measured with a microtiter
platereader (l 570 nm). Serial dilution assay of profilin stan-
dards indicated that the assay was linear between 0.1
and 100 ng additions of profilin per well. Serum samples
were considered reactive with profilin (i.e. positive) if
there was at least one standard deviation difference
between the optical densities obtained from the wells
containing profilin versus those without profilin. Serum
identified as positive gave a linear increase in signal
intensity at concentrations between 10 and 100%.
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Fig. 1 Silver-stained sodium dodecyl sulfate polyacrylamide
gel electrophoresis separation of Escherichia coli transformed
with Zea mays (Zm) PRO1 cDNA. The protein encoded by
ZmPRO1 cDNA was purified by affinity bead slurry separation
as described in Methods. Lane 1, non-transformed E. coli (neg-
ative control); lane 2, E. coli containing pET23a/ZmPRO1
vector; lane 3, E. coli containing pET23a/ZmPRO1 vector +
induced. Arrows show monomeric profilin. Protein molecular
weight marker migrations are listed on the right (in kDa).
Dot-filtration immunoblot
In some instances, a dot filtration immunoblot assay (Bio
Rad, Hercules, CA, USA) using supported nitrocellulose
(0.2 m m pore size) was a necessary alternative to the ELISA
to determine the allergenic potential of ZmPRO1
monomers versus multimers. Profilin was either placed
under reducing (4.5% BME at 95°C for 3 min) or non-
reducing conditions (to favor monomeric or multimeric
conditions, respectively) and subsequently allowed to
adhere to the dot immunoblot (50 ng/well for 2 h) prior to
vacuum filtration to remove the medium from the mem-
brane. The BME was then removed by thorough washing
with TBS and the dot immunoblot was developed with
antibodies similar to the ELISA method, but with an
enhanced metal DAB as the HRP substrate. Quantitative
values for the intensity of immunorecognition (i.e. dark-
ness) were obtained by computer scanning the dot-
filtration immunoblot and using Adobe Photoshop (Adobe
Systems, San Jose, CA, USA) software program (under
histogram, black channel). The average brightness value
was obtained from the fixed number of pixels (486) that
covered each dot and the corresponding darkness value
was calculated by 100 · the inverse of the brightness (i.e.
increased relative value represents increased darkness or
immunoreactivity). Comparisons between the means of
different treatments were made by Student’s t-test.21
RESULTS
Previous characterization of native human profilin has
revealed the formation of functionally relevant tetramers.8
Immunoblot and SDS-PAGE analyses have shown that
approximately 14.8 kDa human profilin monomers form
dimers and tetramers. Furthermore, functional signifi-
cance has been inferred from preferential actin binding to
the tetrameric form. In light of the human profilin find-
ings, the ability of plant profilin to form multimers was
examined. Purified recombinant protein encoded by
the ZmPRO1 cDNA was visualized by silver-stained SDS-
PAGE separation (Figs 1,2a). A predominant band at
14.8 kDa was identified in transformed E. coli, particu-
larly after IPTG induction. Other extraneous bands
(> 30 kDa) presumably include multimeric profilin
and/or cellular proteins that remain with the more conve-
nient PLP affinity bead slurry. It is apparent that ZmPRO1
profilin separated by column chromatography yields
a cleaner preparation that was also studied under both
reduced and non-reduced conditions (Fig. 2a). A pre-
dominant band appeared as expected for monomeric
ZmPRO1 plant profilin (approximately 14.8 kDa), but,
consistent with human profilin, higher molecular weight
proteins remained that were resistant to reducing agents.
The band at approximately 60 kDa (Fig. 2a, + BME)
suggests the formation of a tetramer resistant to reducing
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Fig. 2 Affinity column purified
Zea mays (Zm) PRO1 from trans-
formed Escherichia coli. (a) Similar
to silver-stained sodium dodecyl
sulfate polyacrylamide gel electro-
phoresis in Fig. 1, but profilin
separated by affinity column
chromatography as described in
Methods. Lane 1, reducing condi-
tions (+b-mercaptoethanol (BME)).
Arrow depicts location of mono-
meric profilin; lane 2, non-
reducing conditions (– BME). (b)
Corresponding immunoblot of
samples run in parallel with (a).
Lane 3, + BME; lane 4, – BME.
Rabbit anti-ZmPRO1 and horse-
radish peroxidase-conjugated
secondary goat antirabbit IgG
method was used to visualize
immunologically distinct profilin
proteins. Protein molecular weight
marker migrations are listed on
the left (in kDa).
agents, in addition to the distinct aggregation of proteins
near the top of the gel (> 97 kDa). The larger proteins
become more pronounced under non-reducing con-
ditions (Fig. 2a, – BME) and are associated with a
corresponding loss of monomeric profilin. The presence
of stained proteins that remained in the stacking gel 
(not shown) further support the idea of natural protein
(i.e. profilin) aggregation/multimerization. Any faint pro-
tein represented at 14.8 kDa in the absence of reducing
agent becomes more evident on development of corre-
sponding immunoblots with sensitive substrates (Fig. 2b).
However, western immunoblotting gave inconsistent pos-
itive identification for the higher molecular weight profilin
multimers; presumably this is due to the different efficien-
cies in transfer of various protein sizes, alterations in net
charge that may occur on protein–protein interactions
(e.g. ionic bonds as discussed by Babich et al.8), difficulty
for > 90 kDa profilin multimers in migration from the
stacking gel to the separating gel or a lack of antibody
recognition due to epitope masking when profilin aggre-
gates/multimerization occurs. Indeed, differences in the
observed western immunoblot band intensities (monomer
> tetramer >> higher orders) support these explana-
tions. Collectively, the results suggest that, similar to
native human profilin, immunologically distinct Zea mays
profilin was produced and purified and preferentially
forms multimers.
An ELISA was developed to further immunologically
identify the purified recombinant protein and to provide a
means to study whether human serum from allergic indi-
viduals recognizes ZmPRO1 profilin. Six representative
control wells are pictured (Fig. 3), of which only those
coated with the purified protein elicited a significant colo-
rimetric response. In addition, rabbit antihuman profilin
IgG did not recognize ZmPRO1 profilin (not shown),
which is similar to the inability of rabbit antiplant profilin
IgG to recognize human profilin.18 Thus, a method was
established with a clear signal-to-noise ratio that was
selective for ZmPRO1 profilin and further verified the pro-
duction of immunologically distinct plant profilin.
The developed ELISA was subsequently used to
measure type I allergy patient IgE recognition of ZmPRO1
profilin. Sera from more than 30 individuals were used in
preliminary work to establish conditions for the ELISA and
other methods. Due to depletion of many of the sample
volumes during the course of assay development and 
the lack of signal from the negative patient pool, sera
selected for assay in the final study included a greater
number of miscellaneous and positive samples (eight
negative, 14 miscellaneous, nine positive, shown in
Table 1). There was one positive reactivity to profilin
among patients with no known allergies (one of eight; but
no response from > 20 negative samples in the prelimi-
nary work to establish the assay), minimal reactivity in
those with miscellaneous allergies (three of 14) and sig-
nificant reactivity among those declaring type I allergies
to pollen (three of six). The raw data from the three
samples that gave a positive reaction to profilin (Table 2)
show a strong IgE reactivity to profilin with minimal back-
ground (i.e. a relatively high ratio of the optical densities
when serum was added to profilin-coated wells vs non-
profilin coated wells). The results agree with previous
work that type I allergy patients are immunoreactive to
plant profilin and indicate that the current approach may
be useful to screen for patients with type I allergies.
The allergenic potential of profilin monomers and mul-
timers was tested by dot-filtration immunoblot analysis
(Fig. 4). Although the ELISA is more sensitive and quanti-
tative, the presence of reducing agents used to favor a
monomeric profilin state would hinder the adsorption of
profilin to plastic wells. Thus, a dot blot filtration appara-
tus was used to remove the reducing agents. In all
instances, a greater response was measured from IgE
recognition of + BME/profilin (i.e. profilin as a predomi-
nantly multimeric form) compared with – BME/profilin. In
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Fig. 3 Photograph of wells from enzyme-linked immuno-
sorbent assay developed for plant profilin. Wells 1–2,
secondary antibody alone; wells 3–4, primary antibody + 
secondary antibody; wells 5–6, primary antibody + secondary
antibody + Zea mays (Zm) PRO1 profilin. Tris-buffered saline
+ ZmPRO1 profilin (i.e. negative control) gave no measurable
optical density (not shown).
Table 1 Enzyme-linked immunosorbent assay for human IgE
reactivity with ZmPRO1 profilin




Positive (+) or negative (–) reaction of profilin with serum samples
from the three patient categories (N = 30 samples; quadruplicate
determinations for each point). Zm, Zea mays.
contrast to the relatively weak signal from negative con-
trol patients (i.e. serum(–)), IgE from the positive serum
category displayed a significantly greater recognition of
profilin (regardless of ± BME), thereby implicating higher
profilin orders as allergens.
DISCUSSION
The present work describes the production and purifi-
cation of recombinant ZmPRO1 profilin, which yields
multimeric forms. The protein was subsequently identified
to be immunologically distinct through western immuno-
blot analysis and an ELISA that was developed to assess
allergy patient IgE reactivity. An apparent tetrameric
60 kDa profilin was found in addition to higher multimeric
orders (> 97 kDa) that become amplified under non-
reducing conditions. Although relatively high percentage
acrylamide gels were used to visualize and study
monomeric or lower multimeric orders of ZmPRO1 pro-
filin, it appears that fastidious high profilin multimers
persist, despite exposure to heat and reducing agents. The
findings are remarkably similar to the results obtained on
characterization of native human profilin,8 which has
demonstrated tetramers to be the predominant functional
multimeric form under identical non-reducing conditions.
The recent identification of various plant profilin homo-
polymers and heteropolymers in vitro22 is also consistent
with the present proposal that plant profilin multimers exist
and are the relevant allergenic form. The combination of
near-capacity protein loading and a relatively more sensi-
tive SDS-PAGE staining procedure appears requisite to
identify the additional protein bands, compared with typical
reports with Coomassie blue protein staining (e.g. Babich et
al.8). In addition, plant and human profilins may be similar
in their ability to resist chemical reduction. Computer-based
molecular modeling of human profilin suggests a pro-
filin–profilin interaction may occur that protects some of the
disulfide bonds from harsh reducing agents (Babich et al.,
unpubl. data, 1998; see also Mitterman et al.22). Modeling
studies with plant profilin are needed to further the mole-
cular comparison between plant and human profilin
multimers and to identify relevant epitopes.
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Table 2 Raw data from the positive samples
Patient sample no. OD (· 10–3) of ± profilin coated wells Declared allergies
25 940/80 Hay fever
74 630/340 Trees, pollen
90 214/12 Trees, grasses, strawberries
The ratio of optical densities (OD) from profilin coated versus non-coated wells for the three positive samples identified in Table 1 (mean OD
shown; standard errors were within 10% of the mean).
Fig. 4 Dot-filtration immunoblot of Zea mays (Zm) PRO1 profilin and human IgE. Profilin was adsorbed and filtered onto a dot-fil-
tration apparatus under conditions that favor either monomers (+b-mercaptoethanol (BME)) or multimers (– BME), prior to addition
of serum from patients declaring allergies (serum(+)) or without allergies (serum(–)). Control, rabbit anti-ZmPRO1 antibody (positive
control). Triplicate well determinations of the colorimetric assay are shown for all samples (background, – BME + profilin + sec-
ondary antibody + metal diaminobenzidine substrate; the background was no different when + BME was included). Quantitative
values (mean ± SEM) for the intensity of darkness were calculated as described in Methods and are presented next to each row.
Student’s t-test revealed significance levels of *P < 0.05 or **P < 0.01 for – BME versus corresponding + BME rows.
The existence of plant profilin multimers is supported
by studies on birch pollen allergens. Induction of mouse
and monkey IgE antibodies against recombinant Betv2
(a profilin form) has been demonstrated in vivo,12 albeit
to a lesser extent than another pollen, Betv1. Immuno-
blot and SDS-PAGE analyses have revealed that Betv2
self-associates through disulfide bonds, which have
been suggested to decrease the type I immune response
to the protein. In contrast, the present work is consistent
withthe idea that larger molecules may elicit an immune
response, such as by increased epitope presentation.
Perhaps the ZmPRO1 structure differs from Betv2, in that
epitopes are not blocked by multimerization and/orthe
quaternary structure presents novel epitopes to the
immune system. Further comparisons of the allergenic
potential of various plant profilins are complicated,
because it is also unknown what conformation is
assumed when acquired or introduced in vivo (i.e.
whether they form multimers in vivo or in solution8). In
support of allergenic profilin multimers, recent enzyme
allergosorbent tests and immunoblot inhibition studies
have revealed that IgE from birch pollen allergic patients
is very reactive with 34 and 35 kDa allergens,23 of which
one was thought to be a Betv1 dimer. Future analyses 
of known24 and perhaps alternative epitopes, combined
with computer-based molecular modeling, may shed
light on optimum conformations for the allergenic poten-
tial of profilin.
Several points in support of plant profilin multimeriza-
ton may also be raised from the recent finding of a
60 kDa cross-reactive allergen from mugwort.25 Similar
to human profilin tetramers:8 (i) the size is alike; (ii) it is
resistant to chemical breakdown; (iii) a protein ‘ladder’
has been detected (e.g. approximately 15, 30, 60 kDa)
that is also recognized by pollen allergic patient IgE; and
(iv) the N-terminus is blocked (also supported by Babich
et al., unpubl. data, 1998). Furthermore, (v) trypsin treat-
ment abolishes IgE reactivity against profilin (monomer)
and the 28–30 kDa allergen (dimer?), but not against
the60 kDa protein, which, if the protein were to be a pro-
filin tetramer, is consistent with the notion of a larger
protein being more allergenic; (vi) consistent with the
idea that the larger 60 kDa protein represents profilin
multimers, monoclonal antibodies raised against the 
60 kDa allergen also recognize smaller, but not larger,
proteins from three different plant extracts; (vii) pre-
incubation of patient IgE with the 60 kDa allergen (IgE-
inhibition experiments) reduces subsequent IgE binding to
> 30 kDa proteins from plant extracts, but has little effect
on IgE binding to the smaller MW species (e.g. 14–15
kDa or profilin): the latter point would also be consistent
with the present notion that the 60 kDa protein is com-
prised of smaller proteins (e.g. 2 · 30 kDa dimers) and is
more allergenic; and (viii) complementary DNA were not
obtainable, which would be expected if the protein were
truly a multimer(a point recognized by the investigators).
Collectively, these points are consistent with the present
conclusions; however, they may only represent a strong
coincidence. Future studies should elucidate this issue.
The results support and extend the literature, which
indicates that approximately 20% of pollen allergic indi-
viduals will show IgE reactivity to plant profilin.9,10 Of
the nine patients who declared type I allergies to plant
pollens, three showed significant reactivity to ZmPRO1
profilin with the developed ELISA. Three additional serum
samples from the miscellaneous category (e.g. dust) also
yielded a positive response. This might be expected, con-
sidering that many type I allergy patients often include
dust as an allergen; furthermore, the identification of pro-
filin as an IgE-binding component in latex26 raises the
issue that allergens considered outside the conventional
spectrum of type I candidates may indeed be recognized
by type I allergy patient IgE.
The relatively greater recognition of ZmPRO1 profilin
multimers by IgE reveals novel aspects of plant profilin as
a proposed pan-allergen. Greater recognition of profilin
multimers is not due to simple additive effects, because
the same amount of total profilin was added to each well
used in the dot-immunoblot experiments. Thus, it appears
that profilin multimers act in synergy to either sterically
facilitate access to binding sites or to present unique epi-
topes. In the absence of a larger sample size and defined
conditions to assay specifically for profilin multimer–IgE
interactions, the data thus far also suggest that: (i) more
type I allergy patients than previously estimated have IgE
that recognize profilin; and (ii) profilin multimers are
causative agents for type I allergies. However, conditions
to produce only monomers versus multimers first need to
be defined to pursue these hypotheses. In addition, the
current studies (including preliminary work) and those of
others (e.g. Vrtala et al.,11,12 Pauli et al.,14 Astwood et
al.27) indicate that other methods of detection are feasible
and should be considered in future basic and clinical
applications. Finally, it is recognized that, in order to truly
establish a correlation between type I allergies and reac-
tivity to profilin (particularly multimers or the plant profilin
source), studies with a large number of patients, carefully
screened for allergies by objective methods, are required.
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The current work provides a framework for future
research in the areas of allergy diagnosis and treatment
(e.g. Valenta and Kraft16). Further verification of profilin
as a pan-allergen would raise the issue of whether pro-
filin is the causative agent in a proportion of type I
allergies, as opposed to being only a correlative agent.
Conceivably, therapeutic strategies may be developed to
block profilin epitopes and to prevent or reverse in vivo
self-association, thereby targeting the cause of the
disease.
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